Abstract: An adjustable mass clutch weight for use in a CVT clutch is provided. The adjustable mass clutch weight may include an elongate body having a heel and a tip; a first protrusion having external threads extending from a first side of the elongate body at the heel. The adjustable mass clutch weight may also include a second protrusion having external threads extending from a second side of the elongate body at the heel. The adjustable mass clutch weight may also include a mounting aperture extending through the first protrusion, the elongate body and the second protrusion; and at least one mass adjustment weight with a threaded aperture extending through the at least one mass adjustment weight. The at least one mass adjustment weight may be coupled to the first threaded protrusion and/or the second threaded protrusion to adjust the mass of the adjustable mass clutch weight at the heel of the elongate body.

Abstract: An adjustable mass clutch weight for use in a CVT clutch is provided. The adjustable mass clutch weight may include an elongate body having a heel and a tip; a first protrusion having external threads extending from a first side of the elongate body at the heel. The adjustable mass clutch weight may also include a second protrusion having external threads extending from a second side of the elongate body at the heel. The adjustable mass clutch weight may also include a mounting aperture extending through the first protrusion, the elongate body and the second protrusion; and at least one mass adjustment weight with a threaded aperture extending through the at least one mass adjustment weight. The at least one mass adjustment weight may be coupled to the first threaded protrusion and/or the second threaded protrusion to adjust the mass of the adjustable mass clutch weight at the heel of the elongate body.

Abstract: A rebuild kit for a spider assembly of a CVT clutch is provided. The rebuild kit includes two non-rotating washers, a roller for each location on a spider. The spider may have wear that is over an acceptable amount of wear determined by the manufacturer. The rebuild kit further includes a pin that couples the two non-rotating washers and the roller between the non-rotating washers within the spider. The roller is engaged by a flyweight of the CVT clutch and the non-rotating washers prevent additional wear of the spider while maintaining the roller aligned with the flyweight during operation of the CVT clutch. The rebuild kit may also include an insert within an aperture of the roller, wherein the insert has high temperature resistance, a low coefficient of friction and non-adhesive properties.

Abstract: A rebuild kit for a spider assembly of a CVT clutch is provided. The rebuild kit includes two non-rotating washers, a roller for each location on a spider. The spider may have wear that is over an acceptable amount of wear determined by the manufacturer. The rebuild kit further includes a pin that couples the two non-rotating washers and the roller between the non-rotating washers within the spider. The roller is engaged by a flyweight of the CVT clutch and the non-rotating washers prevent additional wear of the spider while maintaining the roller aligned with the flyweight during operation of the CVT clutch. The rebuild kit may also include an insert within an aperture of the roller, wherein the insert has high temperature resistance, a low coefficient of friction and non-adhesive properties.

Abstract: The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases.

Abstract: The present invention relates to inhibitors of general Formula (I) of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to compounds for preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases.

Abstract: The present invention relates to 4,6-disubstituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, and pharmaceutical compositions containing at least one of said 4,6-di substituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof.

Abstract: The present invention relates to inhibitors of general Formula (I) of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to compounds for preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases.

Abstract: The present invention relates to 4,6-disubstituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, and pharmaceutical compositions containing at least one of said 4,6-di substituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof.